NEW YORK STOCK EXCHANGE, INC. · CI
+3.68% · +$9.95
Cigna Group

Cigna Group

Health Care
$280.68

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
BETA

Why is CI moving today?

Analyzing news articles + insider activity + analyst signals…
About Cigna Group
HOSPITAL & MEDICAL SERVICE PLANS
Founded
Listed
1982
Employees
68K
HQ
US

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

Open
$277.00
Previous close
$270.73
Day high
$284.12
Day low
$275.56
Market cap
$74.25B
IPO
1982-04-01
Country
US
Currency
USD
Data ledger
Quote and day range
As of June 4, 4:00 PM EDT
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

CI insider activity

Cigna Group

Score
Coverage building
Pressure
Net selling
Filings
47
Buys / sells
15 / 32
Net value
-$34.5M
Insiders
9
Named filers
KP
Koka Durga Prasad
Insider
Leadership
KG
Kurian George
Insider
Leadership
CD
Cordani David
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net selling: -$34.5M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-032026-06-01Koka Durga PrasadInsidersell$275.537296,552$201KSEC Form 4
2026-06-022026-05-29Kurian GeorgeInsiderbuy$277.401081,922$30KSEC Form 4
2026-05-142026-05-13Cordani DavidInsiderbuy$197.357,97157,766$1.6MSEC Form 4
2026-05-142026-05-13Cordani DavidInsiderbuy$149.1315,45849,795$2.3MSEC Form 4
2026-05-142026-05-12Cordani DavidInsidersell$298.532,23134,337$666KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 42 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

CI contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CI in this window.
Lobbying spend

CI lobbying filings, year to date.

Registered lobbying filings matched to Cigna Group.

$7.0M
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid Health Issues Defense Pharmacy Labor Issues/Antitrust/WorkplaceHealth Issues Defense PharmacyHealth Issues Taxation/Internal Revenue Code
Filing
$3.5M
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Apr 20, 2026
Filing
$1.7M
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Apr 20, 2026
Filing
$1.6M
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Jan 20, 2026
Latest news · CI
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Loading consensus…
Options · Live
Loading options chain…
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.